ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Cell Pathways


Include trials that are no longer recruiting patients.

7 studies were found.
1.CompletedCP-461 for the Treatment of Crohn’s Disease
Condition: Crohn's Disease
2.TerminatedCP-461 in the Treatment of Patients with Advanced Melanoma
Condition: Malignant Melanoma
3.No longer recruitingDocetaxel With or Without Exisulind in Treating Patients With Non-Small Cell Lung Cancer
Condition: Non-small cell lung cancer
4.CompletedDose-Escalating and Safety Study of CP-461 in Patients with Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
5.TerminatedPhase I-II study to evaluate safety, efficacy and pharmacokinetic interactions between capecitabine (XELODA) and exisulind (APTOSYN) in patients with metastatic breast cancer.
Conditions: Breast Neoplasms; Metastases, Neoplasm
6.No longer recruitingPhase II Study of Taxotere in Combination with Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients
Condition: Non-small cell lung cancer
7.No longer recruitingStudy Using CP-461 to Treat Advanced Prostate Cancer
Condition: Prostate Cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act